Most Popular

Is It Too Late to Buy SpaceX?

Key Points Space Exploration Technologies (NASDAQ: SPCX) has offered investors what may be one of the most exciting moments of the year. The company, more commonly known as SpaceX, completed a record initial public offering, raising $75 billion, then went on to gain 40% from …

Read more

Better Buy: AMD vs. Intel After Intel's Monster Run

Key Points Intel’s stock has surged about 520% over the past year, driven by its foundry turnaround and surging demand for its server processors. AMD’s data center revenue jumped 57% year over year in the first quarter, led by its EPYC processors and Instinct AI …

Read more

Buy These 3 Growth Stocks Now, Ignore the Noise, and Thank Yourself Later

Key Points Chipotle is pushing toward thousands of additional restaurants, Dutch Bros is still in the early stages of its national rollout, and Ulta continues to expand its reach through new brands, experiences, and customer acquisitions. Whether it’s Chipotle’s customer loyalty, Ulta’s dominance in prestige …

Read more

13 Words From Jensen Huang That Spell Good News for Nvidia Shareholders

Key Points Some investors fear that Nvidia‘s (NASDAQ: NVDA) amazing run since the start of the artificial intelligence (AI) boom may come to an end relatively soon, perhaps because demand for its market-leading GPUs (Graphics Processing Units) will cool down, or other companies will continue …

Read more

QURE Was Just the Beginning: 5 Biotech Catalysts I’m Watching Now

QURE just went vertical. These biotech catalysts could be next. Mornings like we had on Wednesday are exactly why I get up and do this show every single day the market is open.  UniQure NV (QURE) opened around $43. Touched $48.88 intraday. Closed in the high $47s. Previous close: …

Read more

The Next Wave of Medical AI Could Mint More Millionaires Than the First — Here Are the Stocks to Own

Key Points Drugmakers and lab platforms putting AI tools to work in real-world drug development. Eli Lilly is using AI partnerships and financial momentum to accelerate and expand weight-loss treatments. Twist Bioscience offers higher-risk upside, supplying synthetic DNA and benefiting from Amazon Bio Discovery’s AI-driven …

Read more

SpaceX Just Identified a $22.7 Trillion Enterprise AI Market. These 2 AI Stocks Are Already Inside the Empire.

Key Points Space Exploration Technologies (NASDAQ: SPCX), or SpaceX, is having a huge week following the biggest IPO in history. The company raised a record $85.7 billion when it went public on June 12 and debuted with a market capitalization of more than $2 trillion. …

Read more

Is NFLX Stock Worth Buying at a Premium P/S or Should Investors Wait?

Netflix NFLX trades at a forward 12-month price-to-sales ratio that sits meaningfully above its broader media and entertainment peer group, a premium that has historically been justified by superior margin expansion, scale in originals and a fast-growing advertising business. From a valuation standpoint, Netflix appears …

Read more

Finally, A Little Good News for EV Stocks — Especially This Detroit Automaker

Key Points U.S. EV sales have jumped to their strongest result since the end of the $7,500 federal EV tax credit. Moreover, EV average transaction prices have declined for 11 consecutive months. Incentives to help drive sales are roughly twice the amount for EVs as …

Read more

9 Stocks Offering Up to 46% Upside Despite a Hawkish Fed

The Fed surprised markets by taking a more hawkish stance than expected, and the markets fell. Some stocks are better positioned to weather higher interest rates for a longer period. Discover nine opportunities well-positioned to outperform in this environment. Wall Street ended sharply lower on …

Read more